European Respiratory Review

Papers
(The H4-Index of European Respiratory Review is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Reply to: “Nicotine or tobacco abstinence?”324
European Respiratory Review, list of peer reviewers 2022198
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients160
European Respiratory Review, list of peer reviewers 2023155
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension137
Live teleultrasound for evaluation of the chest: a systematic review135
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis135
The role of telemonitoring in patients on home mechanical ventilation129
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review111
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis103
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review101
Exacerbations of bronchiectasis91
Context-dependent roles of palmitoylation in acute respiratory distress syndrome: integrating inflammation, cell death and repair87
Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis85
Right-sided heart failure in acute respiratory distress syndrome84
The re-emerging role of linoleic acid in paediatric asthma83
Quality of life in patients with chronic respiratory failure on home mechanical ventilation78
Advance care planning in patients with respiratory failure78
Lung stem cells and respiratory epithelial chimerism in transplantation77
Air pollution as an early determinant of COPD76
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach75
Inhaled corticosteroids for the treatment of COVID-1974
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review71
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell70
Global respiratory health priorities at the beginning of the 21st century68
Epidemiology of severe asthma in children: a systematic review and meta-analysis66
Diaphragm excursion and diaphragm thickening fraction: commonality and conflict65
Imaging technologies in experimental pulmonary fibrosis research: essential tool for enhanced translational relevance63
Factors driving outcome variability in aspiration and community-acquired pneumonia: a meta-analysis60
Quantitative lung ultrasound in neonates: tried-and-tested systems simplify bedside use59
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis59
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools58
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review57
The ageing of people living with cystic fibrosis: what to expect now?55
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension54
Sarcopenia in interstitial lung disease53
Phenotype overlap in the natural history of asthma52
Sex and gender in interstitial lung diseases52
Methods to assess COPD medications adherence in healthcare databases: a systematic review52
Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review51
Pathophysiology and genomics of bronchiectasis49
Nonpharmacological interventions in COPD49
Smoking cessation and vaccination47
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics47
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis46
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review46
0.10244989395142